Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,000
Closed -$458K 246
2023
Q4
$458K Buy
+1,000
New +$493K 0.1% 107
2022
Q1
Sell
-1,574
Closed -$730 184
2021
Q4
$730 Buy
+1,574
New +$697K 0.03% 111
2021
Q2
$693K Buy
+1,565
New +$684K 0.1% 111
2021
Q1
Sell
-6,339
Closed -$2.6M 265
2020
Q4
$2.6M Buy
+6,339
New +$2.64M 0.41% 63
2019
Q3
Sell
-61,862
Closed -$16.4M 136
2019
Q2
$16.4M Buy
+61,862
New +$15.7M 1.91% 14
2016
Q3
Sell
-5,238
Closed -$942K 172
2016
Q2
$942K Buy
+5,238
New +$930K 0.16% 74
2014
Q4
Sell
-28,230
Closed -$3.68M 78
2014
Q3
$3.68M Buy
28,230
+15,730
+126% +$2M 0.34% 47
2014
Q2
$1.6M Buy
+12,500
New +$1.48M 0.12% 71
2014
Q1
Sell
-44,700
Closed -$4.61M 213
2013
Q4
$4.61M Buy
+44,700
New +$4.38M 0.39% 43

Other funds holding HUM

Wexford Capital's HUM Position: Q1 2024 in Review

Wexford Capital sold out of Humana (HUM) in Q1 2024, closing a stake of 1,000 shares — an estimated $458K sold.

Wexford Capital first reported a position in HUM in Q4 2013 and held it in 9 quarters. The position peaked at $16.4M in Q2 2019. 1,029 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

  • Wexford Capital reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
  • Wexford Capital sold 1,000 Humana shares in Q1 2024, an estimated $458K.
  • Wexford Capital first reported a position in Humana in Q4 2013 and held it in 9 quarters.
  • Wexford Capital's Humana position peaked at $16.4M in Q2 2019.
  • 1,029 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Wexford Capital's 13F filing for Q1 2024, filed 15 May 2024.